Axa Parenterals Limited (APL) is a prominent manufacturer in the pharmaceutical industry, providing a range of services designed to meet the needs of global healthcare. With a strong focus on quality and compliance, APL, together with its 100% subsidiary Heilsa Life Sciences (HLS), is engaged in the production of various injectable products, including general injectables and liposomal formulations. APL operates with multiple Rommelag filling machines and holds significant certifications such as PIC/S and WHO-GMP, making it a reliable partner for exporting products to 61 countries. The company’s key offerings include respules, single-use eye drops, multi-dose eye drops, and large volume parenterals (LVP), whilst HLS specializes in manufacturing general injectable vials, including emulsion and lyophilized products.

Services include:
– Regulatory Services
– Containment
– Injectables
– Packaging
– Finished Dosage Forms

Axa Parenterals Ltd continues to seek collaborations in the form of CDMO and marketing alliances in Europe and around the globe, further cementing its position as a trusted supplier in the pharmaceutical sector. For more information, please visit axapar.com.